Advarra, Inc.

Advarra, Inc. is a clinical research services and technology company combining an independent Institutional Review Board (IRB) with software for running clinical trials. The company provides ethical review of research alongside platforms for trial management, regulatory document management and data analytics. Its IRB Services arm has conducted ethical review for more than four decades and supports the majority of industry-sponsored trials, working with all top-20 pharmaceutical companies and with more than 72,000 research sites.

The product portfolio spans both services and software. CIRBI is Advarra's proprietary platform for IRB management, while OnCore and Clinical Conductor are clinical trial management systems (CTMS) and eReg handles regulatory documents. Braid, an AI-powered data and analytics platform, is designed to supply operational intelligence for study design and decision-making. In addition to IRB Services, the company offers Institutional Biosafety Committee (IBC) Services, Data Monitoring Committee (DMC) Services and broader clinical trial management solutions with operational expertise.

Advarra's clients range from emerging biotechs to leading contract research organisations (CROs) and academic and institutional research sites. The company works across therapeutic areas including oncology, paediatrics, neurodegenerative and CNS diseases, infectious diseases, metabolic diseases and rare diseases, with stated expertise in advanced modalities such as cell and gene therapy. Its stated focus is on keeping research moving through efficient, rigorous review and connected clinical trial operations.